|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
|
|---|---|---|---|---|---|
| REVENUE | |||||
| OPERATING EXPENSES: | |||||
| Costs of revenue | |||||
| Costs of revenue | |||||
| Professional fees and related costs | |||||
| General and administrative | |||||
| Amortization of patents | |||||
| Stock-based compensation | |||||
| TOTAL OPERATING EXPENSES | |||||
| OPERATING LOSS | |||||
| Interest and dividend income, net | |||||
| Net realized and unrealized gain on marketable securities | |||||
| Total other income, net | |||||
| LOSS BEFORE INCOME TAXES AND SHARE OF NET LOSSES OF EQUITY METHOD INVESTEE | |||||
| Current | |||||
| Deferred taxes, net | |||||
| Total income taxes benefit | |||||
| INCOME (LOSS) BEFORE SHARE OF NET LOSSES OF EQUITY METHOD INVESTEE: | |||||
| LOSS BEFORE SHARE OF NET LOSSES OF EQUITY METHOD INVESTEE: | |||||
| SHARE OF NET LOSSES OF EQUITY METHOD INVESTEE | |||||
| NET LOSS | |||||
| Net unrealized holding gain on corporate bonds and notes arising during the year, net of tax | |||||
| COMPREHENSIVE LOSS | |||||
| Basic | |||||
| Diluted | |||||
| Cash dividends declared per share | |||||
Loading...